Affiliation:
1. Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
Abstract
Asthma is a chronic inflammatory condition, and the main features include airway hyper-responsiveness and inflammation of the airway with the accumulation of inflammatory cells. Increased level of plasma fibrinogen and serum amyloid A suggests the involvement of systemic inflammation in asthma. C-reactive protein (CRP) is an acute-phase protein that produced mainly by hepatocytes and is an inflammatory marker. CRP levels monitoring is useful in the evaluation of early inflammation and efficacy of treatment in acute-phase illnesses. Several studies show that asthma alone can cause an increase in high-sensitivity CRP (hs-CRP) when compared with the healthy controls. Besides that, steroid-naïve patients have a higher mean value of hs-CRP levels compared with those on inhaled corticosteroid. Furthermore, studies have shown that an elevated hs-CRP level has a positive correlation with non-atopic asthma but not atopic asthma. Additionally, an increase in serum hs-CRP levels correlates with the severity of asthma. Therefore, serum hs-CRP is a useful surrogate marker to predict the severity of inflammation of the bronchus in asthma and assess the asthma status.
Reference58 articles.
1. Wouters EF. The systemic face of airway diseases: the role of C-reactive protein. Eur Respir J. 2006;27(5):877-9.
2. Monadi M et al. Serum C-reactive protein in asthma and its ability in predicting asthma control, a case-control study. Caspian J Intern Med. 2016;7(1):37-42.
3. Kadakal F et al. The assessment of high sensitivity C-reactive protein as a systemic marker in moderate asthma patients and changing levels by inhaled corticosteroids. J Pak Med Assoc. 2013;63(7):893-8.
4. Takemura M et al. High sensitivity C-reactive protein in asthma. Eur Respir J. 2006;27(5):908.
5. Kasayama S et al. Asthma is an independent risk for elevation of plasma C-reactive protein levels. Clinica Chimica Acta. 2009;399(1):79-82.